Aspects of the disclosure relate to methods for treating disorders using agents for promoting hypoglossal motoneuron excitability. In some instances the disorders include obstructive sleep apnea (OSA), cataplexy, attention deficit/hyperactivity disorder (ADHD), attention deficit disorder (ADD) or depression. Related products are also included within the invention.
